Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 829 of 1,261
  1. US 8658853

    Low affinity FcγR deficient mice

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted
  2. US 8658168

    Compositions and methods for homoconjugates of antibodies which induce growth arrest of apoptosis of tumor cells

    The Board of Regents of the University of Texas System · Granted Feb 25, 2014 · Expires Feb 20, 2034

    granted
  3. US 8652516

    Doxycycline formulations, and methods of treating rosacea

    Cerovene, Inc. · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  4. US 8653055

    Corticosteroid having low systemic absorption

    Teva Animal Health, Inc. · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  5. US 8653034

    Compositions and methods comprising phosphatidylethanolamine-binding peptide derivatives

    The Board of Regents of the University of Texas System · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  6. US 8653057

    Prophylactic perioperative testosterone supplementation for protection of and recovery of function

    The Regents of the University of California · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  7. US 8653033

    Method for administering omega-conopeptide

    Jazz Pharmaceuticals International III Limited · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  8. US 8652836

    Defective ribosomal products in blebs (DRibbles) and methods of use to stimulate an immune response

    Providence Health System · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  9. US 8652787

    Use of ERBB4 as a prognostic and therapeutic marker for melanoma

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  10. US 8652492

    Wet granulation using a water sequestering agent

    Rigel Pharmaceuticals, Inc. · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  11. US 8652512

    Nebulized liposomes for the pulmonary application of drug compounds

    United Therapeutics Corporation · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  12. US 8652503

    Bone paste

    Regeneration Technologies, Inc. · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  13. US 8652475

    Inhibition of factor B, the alternative complement pathway and methods related thereto

    The Regents of the University of Colorado, a Body Corporate · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  14. US 8652467

    Dek protein compositions and methods of using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  15. US 8652445

    Dental compositions with sensitivity relief

    DISCUS DENTAL, LLC · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  16. US 8652443

    Foamable microemulsion compositions for topical administration

    Precision Dermatology, Inc. · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  17. US 8652458

    Tissue graft with non-aligned fiber matrix retains mesenchymal progenitor cells on the non-injury-facing side

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  18. US 8652366

    Aerosol-mediated particle synthesis

    The Board of Regents of the University of Texas System · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  19. US 8653103

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  20. US 8653137

    Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same

    United Therapeutics Corporation · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  21. US 8653088

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  22. US 8653094

    Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)-pyrimidin-4-yl)phenyl)propanoate and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  23. US 8653061

    Acetylcysteine composition and uses thereof

    Cumberland Pharmaceuticals Inc. · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted
  24. US 8653060

    Formulations of 6-mercaptopurine

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.